The store will not work correctly when cookies are disabled.
We use cookies for optimal website function and to better serve our customers. By continuing to browse you agree to the storing of cookies on your device. See our privacy policy for details.
Allow cookies Deny
CAS NO.: 611240-68-7;8-chloro-2-(trifluoromethyl)imidazo[1,2-a]pyrazine. PROPERTIES: This chlorinated heterocycle presents as a pale yellow solid with a molecular weight of approximately 226.6 g/mol. The 8-chloro-2-(trifluoromethyl)imidazo[1,2-a]pyrazine combines a chloro and trifluoromethyl substituents on a fused imidazopyrazine ring system. It exhibits limited aqueous solubility but good dissolution in polar aprotic solvents like THF and CHCl3. Stability characterization reveals sensitivity to nucleophilic aromatic substitution and base-catalyzed ring-opening, necessitating storage at 2-8 degree Celsius in amber glass containers. Handlers should employ powder hoods with HEPA filtration and use cut-resistant gloves during handling. Skin contact may cause mild irritation requiring thorough washing. Inhalation may induce respiratory tract irritation; treatment includes fresh air and medical evaluation. Eye exposure requires extended rinsing and possible corticosteroid application. Waste should be hydrolyzed with dilute acid prior to disposal. APPLICATIONS: The 8-chloro-2-(trifluoromethyl)imidazo[1,2-a]pyrazine functions as a key intermediate in the synthesis of various pharmaceuticals. Its fused heterocycle provides privileged structure characteristics for receptor tyrosine kinase targeting. Research teams utilize this compound as a starting material for creating kinase inhibitors and ion channel modulators. The chloro and trifluoromethyl groups enhance metabolic resistance and binding affinity in resulting drug candidates. Additionally, the compound undergoes Buchwald-Hartwig amination for constructing anilinic systems. Its unique substitution pattern makes it valuable in the development of fluorescent probes and bioimaging agents.